Mid Atlantic Financial Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.59M Buy
11,201
+206
+2% +$50.8K 0.17% 125
2021
Q2
$2.52M Buy
10,995
+903
+9% +$181K 0.17% 125
2021
Q1
$1.89M Sell
10,092
-240
-2% -$46.9K 0.14% 143
2020
Q4
$1.74M Buy
10,332
+699
+7% +$104K 0.13% 151
2020
Q3
$1.37M Buy
9,633
+1,763
+22% +$273K 0.12% 155
2020
Q2
$1.29M Sell
7,870
-55
-0.7% -$8.44K 0.12% 146
2020
Q1
$1.1M Sell
7,925
-520
-6% -$71.4K 0.13% 143
2019
Q4
$1.11M Buy
8,445
+242
+3% +$28.1K 0.1% 193
2019
Q3
$917K Buy
8,203
+374
+5% +$41.6K 0.1% 216
2019
Q2
$867K Sell
7,829
-1,922
-20% -$226K 0.09% 239
2019
Q1
$1.26M Buy
9,751
+1,395
+17% +$170K 0.14% 137
2018
Q4
$967K Buy
+8,356
New +$933K 0.12% 162

Other funds holding LLY

Mid Atlantic Financial Management's LLY Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Eli Lilly (LLY) stake by 1.9% in Q3 2021, buying an estimated $50.8K and bringing the position to 11,201 shares worth $2.59M. The position accounts for 0.17% of the portfolio, ranked #125.

Mid Atlantic Financial Management first reported a position in LLY in Q4 2018 and has held it in 12 quarters since. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • Mid Atlantic Financial Management held 11,201 shares of Eli Lilly worth $2.59M as of Q3 2021.
  • Mid Atlantic Financial Management bought 206 Eli Lilly shares in Q3 2021, an estimated $50.8K.
  • Eli Lilly made up 0.17% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #125 holding.
  • Mid Atlantic Financial Management first reported a position in Eli Lilly in Q4 2018 and has held it in 12 quarters since.
  • 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.